Search For

The contribution of proteoglycans to heterogeneity and temozolomide resistance of glioblastoma cells

Clinical resistance predictors to first-line VEGFR-TKI monotherapy for metastatic renal cell carcinoma: a retrospective multicenter real-life case series

Endocrine therapy in metastatic breast cancer-more than just CDK4/6 inhibitors

Final results of a 2:1 control-case observational study using interferon beta and interleukin-2, in addition to first-line hormone therapy, in estrogen receptor-positive, endocrine-responsive metastatic breast cancer patients

Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies

Bulbine frutescens phytochemicals as novel ABC-transporter inhibitor: a molecular docking and molecular dynamics simulation study

Epithelial-mesenchymal transition: a hallmark in pancreatic cancer stem cell migration, metastasis formation, and drug resistance

Targeting epithelial-mesenchymal transition - an ongoing wild goose chase

High-risk HPVs, microbiota and epithelial carcinogenesis: state of the art and research contribution of in vitro 3D models

Exploiting autophagy in multiple myeloma

Role of autophagy in therapeutic resistance of glioblastoma

Chemotherapy-induced immunological breast cancer dormancy: a new function for old drugs?